SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Arterial Vascular Engineering AVEI -- Ignore unavailable to you. Want to Upgrade?


To: gbh who wrote (240)6/16/1998 9:53:00 AM
From: Jeffrey L. Henken  Read Replies (1) | Respond to of 410
 
Easy deal to figure out. AVEI does not really have $2.1 billion to spend on an acquisition like Schneider. No huge acquisition expense for AVE. That's why the stock is up. They will be buying someone and I think I may know who that might be. I've been sending out an e mail update on stock pick's by Brenda Greer(Multi-Millionaire Private Investor) in which I predicted this buyout by BSX.

Who is next?

Who might be a great fit for AVE?

Check out the ABMI thread:

Subject 19556

Regards, Jeff